END STAGE RENAL DISEASE (ESRD)
Clinical trials for END STAGE RENAL DISEASE (ESRD) explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE (ESRD) trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE (ESRD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Made blood vessel could free dialysis patients from catheters
Disease control OngoingThis Phase 3 trial tests a lab-grown blood vessel (ATEV) against the standard surgically created fistula in 121 women with end-stage kidney disease who need dialysis. The goal is to see if the ATEV allows more days without a catheter and reduces infections over 12 months. If succ…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a dialysis boost fix malnutrition in kidney patients?
Disease control ENROLLING_BY_INVITATIONThis study tests a special dialysis fluid containing amino acids (protein building blocks) to see if it can improve the nutritional status of adults with end-stage kidney disease who are on peritoneal dialysis. About 50 participants will replace one daily dialysis bag with this s…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE4 • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could your own fat cells save your dialysis access?
Disease control OngoingThis early-stage trial tests whether a patient's own fat-derived stem cells, applied during surgery, can prevent dialysis fistulas from failing. About 74 adults with advanced kidney disease will receive either stem cells or a placebo. The goal is to see if the treatment improves …
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could testosterone boost kidney transplant success?
Disease control OngoingThis study looks at whether giving testosterone to men with low testosterone and kidney failure can help them recover better after a kidney transplant. About 50 men will receive testosterone before and after their transplant, and their safety and recovery will be compared to a si…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Dialysis patients try exercise to fight muscle weakness
Symptom relief OngoingThis study tests whether adding a structured exercise program during dialysis sessions can improve strength, walking ability, and quality of life for people with end-stage kidney disease. About 800 patients will be randomly assigned to either dialysis plus exercise or dialysis al…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: The First People's Hospital of Yunnan • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Which numbing drug works best for dialysis access surgery?
Symptom relief OngoingThis study tests two numbing medicines, ropivacaine and lidocaine, in 40 adults with end-stage kidney disease who need surgery to create a blood vessel connection (fistula) for dialysis. Patients are randomly assigned to receive one of the two drugs during surgery, and neither th…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Phase: PHASE4 • Sponsor: The First People's Hospital of Lianyungang • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Dialysis vein mystery: researchers hunt for clues to prevent blockages
Knowledge-focused OngoingThis study follows 96 people with end-stage kidney disease who need a brachiocephalic fistula for dialysis. Researchers collect data from exams, blood tests, and imaging to track changes in the vein over time. The goal is to learn what causes cephalic arch stenosis, a common narr…
Matched conditions: END STAGE RENAL DISEASE (ESRD)
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC